test altFunding OpportunitiesAward ManagementComliance Review and OversightEducation and TrainingTechnology Transfer
Office of Research and Technology Management
Promoting Research, Advancing Scholarship, Fostering Innovation
Identify Funding Oportunities Proposal Development Award Management
Compliance Review and Oversight Education and Training Technology Transfer


Welcome from the Vice President for Research

CWRU researchers are among the most distinguished in the world. We have 16 Nobel Laureates among current and former faculty and alumni, 4 members of the National Academies of Sciences, 7 members of the National Academy of Engineering, and 8 members of the Institute of Medicine. We also partner with artistic and cultural institutions on a broad range of projects that make important scholarly contributions in the humanities and social sciences.

Extraordinary research requires an outstanding infrastructure. Our Office of Research & Technology Management provides support to seek out grant funding, to facilitate industrial sponsorship, and to transfer university technologies to the marketplace. This is a place for people driven to make a difference, and our office exists to help them succeed.

Contact us. We want you to see what our campus can offer.

Dr. Suzanne Rivera


Research Matters

Research Matters

Use the following link in order to view previous editions of Research Matters and Research News and Updates Research Matters Archive .




Latest News

Research Newsletter
July 14, 2015  

Take Advantage of All Pivot Has to Offer

For years, Community of Science (COS) has been recognized around the world for its funding from a wide variety of sources as well as its access to the world’s research community.

CWRU has subscribed to COS's new product, Pivot, which provides you the edge by bringing together the right research opportunities, funding, and people—quickly and easily. It provides global and local connections that strengthen research by exploring new avenues for funding and collaboration—for faculty, staff researchers, and graduate students.

Pivot can:

  • provide access to the most comprehensive global source of funding opportunities;
  • identify research expertise from within or outside of CWRU;
  • foster collaboration by cultivating essential partnerships and alliances; and
  • build strong network connections for future opportunities.
Learn more about how to use all the features Pivot has to offer.

Sign up for a Pivot Webinar: https://refworks.webex.com/refworks/onstage/g.php?p=4&t=m.

 
CDC: Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation

The purpose of this program is to enhance support to family members of patients with a suspected or diagnosed case of human prion disease as well as enhance support for national surveillance for CJD and its emerging variants by (1) providing family members of such patients with easy access to consultations with persons experienced and knowledgeable about practical issues related to this disease, 2) facilitating educational and other mutually beneficial interaction of researchers with family members of CJD patients (3) increasing general awareness about CJD and (4) increasing the number of autopsies of suspected CJD cases.

Application Deadline: August 14, 2015.

For more information visit the Grants.Gov webpage.

 
Department of Defense

The Department of Defense has announced the following new funding opportunities:

Department of the Army - USAMRAA

DoD Duchenne Muscular Dystrophy Investigator-Initiated Research Award

DoD Duchenne Muscular Dystrophy Therapeutic Idea Award

DoD Duchenne Muscular Dystrophy Translational Leverage Award

DoD Lung Cancer Concept Award

 

Department of Defense

The Department of Defense has announced the following new funding opportunities:

Department of the Army - USAMRAA

FY15 Peer Reviewed Cancer Idea Award with Special Focus

FY15 Peer Reviewed Cancer Career Development Award

FY15 Peer Reviewed Cancer Translational Team Science Award

 
NIH Center for Accelerated Innovations at Cleveland Clinic

The NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC) Announces the Request for Applications (RFA) for the third funding cycle for Cleveland Clinic, Case Western Reserve University, The Ohio State University, Cincinnati Children’s Hospital, and University of Cincinnati.

Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, pulmonary, blood or sleep-related disorders. We are seeking projects such as therapeutics (e.g. drugs, biologics), preventatives, diagnostics, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health.

The NCAI-CC will provide funding and project assistance to advance the development of high priority early-stage technologies within the mission areas of the NHLBI (cardiovascular, lung, blood and sleep disorders).

Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.

Letter of Intent Deadline: August 19, 2015

For more information visit the NCAI-CC webpage.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.